Chapter title |
The Introduction and Clinical Application of Cell-Free Tumor DNA
|
---|---|
Chapter number | 4 |
Book title |
Computational Systems Biology
|
Published in |
Methods in molecular biology, January 2018
|
DOI | 10.1007/978-1-4939-7717-8_4 |
Pubmed ID | |
Book ISBNs |
978-1-4939-7716-1, 978-1-4939-7717-8
|
Authors |
Jun Li, Renzhong Liu, Cuihong Huang, Shifu Chen, Mingyan Xu, Li, Jun, Liu, Renzhong, Huang, Cuihong, Chen, Shifu, Xu, Mingyan |
Abstract |
Cell-free tumor DNA (ctDNA) is a kind of potential tumor biomarkers originated from cancer lesion in the circulating liquids. Liquid biopsy, as a minimally invasive or noninvasive manner, is a cutting-edge technology to detect ctDNA and other circulating biomarkers in the blood or other body fluids. ctDNA is mostly used for cancer patients to select targeted drugs in clinical application. In addition, ctDNA could also be applied to monitor tumor progression and recurrence. In conclusion, ctDNA is a very promising tumor biomarker for diagnosis and monitoring, which would increasingly become a routine clinical application in recent years. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 19 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 3 | 16% |
Student > Ph. D. Student | 3 | 16% |
Other | 2 | 11% |
Researcher | 2 | 11% |
Librarian | 1 | 5% |
Other | 3 | 16% |
Unknown | 5 | 26% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 6 | 32% |
Biochemistry, Genetics and Molecular Biology | 5 | 26% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 5% |
Immunology and Microbiology | 1 | 5% |
Agricultural and Biological Sciences | 1 | 5% |
Other | 0 | 0% |
Unknown | 5 | 26% |